VRDN

Conviction 69HealthcareScan · Mon, Aug 10, 2026

Bearish harami

VRDN$23.07-2.20%

ResistanceSupportVol 14Insider buy

Vol MA14 2.46M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Viridian Therapeutics, Inc.\DEPHARMACEUTICAL PREPARATIONSwww.viridiantherapeutics.com ↗

Price23.07

Change-2.20%

Gap-1.23%

Rel volume5.35×

Avg volume2.24M

Avg $ vol46.05M

SMA 2019.90

SMA 5018.48

SMA 20023.95

Price vs 50+24.86%

Price vs 200-3.68%

MA stackmixed

50/200 cross—

Supertrendup · 20.17

RSI (14)71

MACD hist0.37

MACD crossbull · 4d

Stoch %K / %D90 / 96

ADX (14)33

+DI / −DI38 / 11

RSI divergence—

MACD divergence—

ATR %+4.23%

ADR %4.53%

52w high33.78

52w low13.30

From 52w high-31.71%

Above 52w low+73.46%

New 52w highNo

SqueezeOff

Bollinger width30.57%

%B1.02

Donchian pos91.10%

Donchian high23.61

Donchian low17.54

AVWAP (52w high)20.23

vs AVWAP high+14.03%

AVWAP (52w low)18.26

vs AVWAP low+26.31%

OBV trendFlat

Chaikin MF (20)0.23

Today vs 20d5.35×

Avg vol (14d)2.46M

Avg vol (20d)2.24M

Avg $ vol (20d)46.05M

Market cap2.61B

RS 3m (vs SPY)+33.07%

RS 6m (vs SPY)-33.24%

RS line new highYes

Trend template3/8

Technical rank49.9

1 week+19.47%

1 month+16.87%

3 months+38.89%

6 months-21.13%

1 year+39.56%

YTD-24.80%

P/E-7.63

P/B3.95

P/S458.05

P/FCF-9.44

EPS-5.31

Div yield—

ROE-51.74%

ROA-31.22%

Debt/Eq0.04

Current16.95

EV/EBITDA-7.21

Gross margin—

Net margin—

Rev growth-12.00%

EPS growth-26.91%

Price target33.91

Target upside46.99%

Analyst ratingBuy

Institutional105.97%

Ent. value2.62B

Revenue2.11M

Net income-127.12M

Gross profit—

Free cash flow-276.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out103.07M

Employees252

ListedWed, Jun 18, 2014

Free float86.34M

Float %90.5%

Short interest18.92M

Days to cover9.9d

Short volume28.6%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.05 vs −$0.97

Last surprise-8.3% miss

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank49.9 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRDN

All disclosures →

No recent disclosed trades by Congress in VRDN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRDN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Fairmount Funds Management LLC Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13
Fairmount Healthcare Fund II L.P. Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13
Fairmount Healthcare Fund II GP LLC Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13

SEC filings

EDGAR filings in VRDN · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.